SCOTTSDALE, Ariz.--(BUSINESS WIRE)--May 29, 2018--
Magellan
Health, Inc. (NASDAQ: MGLN) announced today that Swati Abbott and
Matthew J. Simas have been elected at the 2018 annual meeting of
shareholders to Magellan’s board of directors. Both Abbott and Simas
were nominated for election to the board to fill the seats previously
held by Kay Coles James, president of the Heritage Foundation, and Mary
Sammons, former chairperson and CEO of Rite Aid Corporation.
“We are fortunate to have two experienced healthcare industry leaders
join our board of directors,” said Barry M. Smith, chairman and chief
executive officer of Magellan Health. “As we continue to focus on
leading humanity to healthy, vibrant lives, Matthew and Swati’s combined
knowledge and skills will benefit our work to bring innovative solutions
to the fastest growing, most complex areas of healthcare."
Since 2011, Abbott has served as the president and chief executive
officer of Health Intelligence Company, LLC, doing business as Blue
Health Intelligence, a healthcare data and analytics company. She has
significant knowledge and experience in healthcare data analytics and
managed care. Prior to joining Blue Health Intelligence, she was the
president of MEDai, Inc., an industry leader in predictive analytics
which was acquired by Reed Elsevier in 2008. She also served as managing
director for the Medical Management Strategic Business Unit at ViPS.
Abbott currently serves as a director of Prognos, Inc., a private
healthcare data analytics company, and The Family Institute, a
non-profit agency involved in clinical service, education and research.
Simas currently serves as the director of Truveris, Inc., a private
healthcare services company providing transparency to the prescription
drug ecosystem through data-driven innovations. He has 30 years of
experience in the healthcare industry with extensive expertise in health
technology and in the pharmacy benefits management (PBM) industry. Simas
was founder, chairman and chief executive officer of MedInitiatives,
Inc., a provider of business intelligence technology and data analytics
serving the pharmacy benefit manager, payer and pharma markets, which
was acquired by IMS Health in 2007. He also held previous roles as a
director of MedImpact Healthcare Systems, Inc., and the executive
chairman of BusinessOne Technologies, Inc. Simas also served as the
chairman and interim chief executive officer of Alliance Health (now
UpWell), a private healthcare company providing services to members with
chronic health conditions.
“We thank Kay and Mary for their valuable contributions over the years
and we greatly appreciate their guidance and leadership as members of
our board,” said Smith.
About Magellan Health: Magellan
Health, Inc. is a leader in managing the fastest growing, most
complex areas of health, including special populations, complete
pharmacy benefits and other specialty areas of healthcare. Magellan
supports innovative ways of accessing better health through technology,
while remaining focused on the critical personal relationships that are
necessary to achieve a healthy, vibrant life. Magellan's customers
include health plans and other managed care organizations, employers,
labor unions, various military and governmental agencies and third-party
administrators. For more information, visit MagellanHealth.com.
(MGLN-GEN)
View source version on businesswire.com: https://www.businesswire.com/news/home/20180529006167/en/
Source: Magellan Health, Inc.
Magellan Health, Inc.
Media Contact:
Lilly Ackley,
860-507-1923
ackleyl@magellanhealth.com
or
Investor
Contact:
Joe Bogdan, 860-507-1910
jbogdan@magellanhealth.com
